Oncogenic MicroRNAs Characterization in Clear Cell Renal Cell Carcinoma
Authors:
Open Access
- 8 December 2015
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 16 (12) , 29219-29225
Abstract
A key challenge for the improvement of clear cell renal cell carcinoma (ccRCC) management could derive from a deeper characterization of the biology of these neoplasms that could greatly improve the diagnosis, prognosis and treatment choice. The aim of this study was to identify specific miRNAs that are deregulated in tumor vs. normal kidney tissues and that could impact on the biology of ccRCC. To this end we selected four miRNAs (miR-21-5p, miR-210-3p, miR-185-5p and miR-221-3p) and their expression has been evaluated in a retrospective cohort of formalin-fixed paraffin-embedded (FFPE) tissues from 20 ccRCC patients who underwent surgical nephrectomy resection. miR-21-5p and miR-210-3p resulted the most significantly up-regulated miRNAs in this patient cohort, highlighting these onco-miRNAs as possible relevant players involved in ccRCC tumorigenesis. Thus, this study reports the identification of specific oncogenic miRNAs that are altered in ccRCC tissues and suggests that they might be useful biomarkers in ccRCC management.Keywords
This publication has 27 references indexed in Scilit:
- Tumor suppressor microRNAs: A novel non‐coding alliance against cancerFEBS Letters, 2014
- MicroRNA-Regulated Pathways in Hematological Malignancies: How to Avoid Cells Playing Out of TuneInternational Journal of Molecular Sciences, 2013
- Comprehensive molecular characterization of clear cell renal cell carcinomaNature, 2013
- Cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- State of the Science: An Update on Renal Cell CarcinomaMolecular Cancer Research, 2012
- MicroRNA: basic mechanisms and transcriptional regulatory networks for cell fate determinationCardiovascular Research, 2008
- MicroRNAs: regulators of oncogenesis and stemnessBMC Medicine, 2008
- Advanced Renal Cell CarcinomaDrugs, 2007
- MicroRNA Signatures in Human CancersNature Reviews Cancer, 2006
- MicroRNAsCell, 2004